TY - JOUR T1 - Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit JF - Clinical Medicine JO - Clin Med SP - 54 LP - 54 DO - 10.7861/clinmedicine.19-2-s54 VL - 19 IS - Suppl 2 AU - Rosemeen Parkar AU - Ekaterini Boleti Y1 - 2019/03/01 UR - http://www.rcpjournals.org/content/19/Suppl_2/54.abstract ER -